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ORIGINAL RESEARCH
Left Atrial Dynamics Is Altered in Young 
Adults With Cryptogenic Ischemic Stroke: 
A Case- Control Study Utilizing Advanced 
Echocardiography
Jani Pirinen , MD, PhD; Vesa Järvinen, MD, PhD; Nicolas Martinez-Majander, MD; Juha Sinisalo, MD, PhD; 
Pauli Pöyhönen, MD, PhD; Jukka Putaala, MD, PhD
BACKGROUND: Ischemic stroke in young individuals often remains cryptogenic. Some of these strokes likely originate from the 
heart, and atrial fibrosis might be one of the etiological mechanisms. In this pilot study, we investigated whether advanced 
echocardiography findings of the left atrium (LA) of young cryptogenic stroke patients differ from those of stroke- free controls.
METHODS AND RESULTS: We recruited 30 cryptogenic ischemic stroke patients aged 18 to 49 years and 30 age- and sex- 
matched stroke- free controls among participants of the SECRETO (Searching for Explanations for Cryptogenic Stroke in the 
Young: Revealing the Etiology, Triggers, and Outcome) study (NCT01934725). We measured basic left ventricular parameters 
and detailed measures of the LA, including 4- dimensional volumetry, speckle tracking epsilon, strain rate, and LA appendix 
orifice variation. Data were compared as continuous parameters and by tertiles. Compared with controls, stroke patients had 
smaller LA reservoir volumes (10.2 [interquartile range, 5.4] versus 13.2 [5.4] mL; P=0.030) and smaller positive epsilon val-
ues (17.8 [8.5] versus 20.8 [10.1]; P=0.023). In the tertile analysis, stroke patients had significantly lower left atrial appendage 
orifice variation (3.88 [0.75] versus 4.35 [0.90] mm; P=0.043), lower LA cyclic volume change (9.2 [2.8] versus 12.8 [3.5] mL; 
P=0.023), and lower LA contraction peak strain rate (−1.8 [0.6] versus −2.3 [0.6]; P=0.021). We found no statistically significant 
differences in left ventricular measures.
CONCLUSIONS: This preliminary comparison suggests altered LA dynamics in young patients with cryptogenic ischemic stroke, 
and thus that LA wall pathology might contribute to these strokes. Our results await confirmation in a larger sample.
Key Words: brain infarction ■ case-control study ■ echocardiography ■ stroke ■ young, stroke in
Ischemic stroke can occur because of cardioem-bolism. Some cardiac diseases are categorized as high- risk sources because of an >2% annual 
ischemic stroke risk.1 A portion of ischemic strokes 
remain cryptogenic, that is, with undetermined etiol-
ogy despite intensive diagnostic investigations. Stroke 
at younger ages is particularly prone to be of a cryp-
togenic nature,2 when there is limited evidence for 
targeted secondary prevention and counseling on 
prognosis.
Embolic stroke of undetermined source (ESUS) is 
a new concept of stroke etiology and represents a 
defined subgroup of cryptogenic stroke, in which the 
patient has a neuroimaging pattern typical for em-
bolic strokes, which excludes deep, that is, lacunar, 
infarctions. In ESUS, no definite source of embolism 
may be found, which also excludes high- risk sources 
of cardioembolism.3 Intensive research has been fo-
cused on the possibility of at least part of the ESUS 
cases being of cardiac origin, whereas ESUS remains 
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a heterogeneous patient group.4 Also, there is no hard 
evidence that some lacunar infarctions could not orig-
inate from cardioembolic sources.5 Silent atrial fibrilla-
tion (AF) is also thought to be the embolic source for 
part of the ESUS patients, although symptom sever-
ity of ESUS and AF- related strokes does not match.6 
However, AF is rare in young people, and hence most 
cryptogenic strokes in the young, including ESUS 
cases, are most likely not attributable to silent AF.7 
Studies suggest that some ESUS patients have slight 
differences in cardiac structure and function, com-
pared with stroke patients with an established non-
cardiac stroke etiology. These include left atrial (LA) 
appendage (LAA) morphology, P- wave terminal force 
on ECG, and LA enlargement.8,9 A theory on atrial 
cardiopathy has emerged, and a pathological throm-
bogenic atrial substrate is thought to be one of the fac-
tors in ESUS pathogenesis.8 Atrial cardiopathy can be 
principally a reflection of the same pathology as AF, 
that is, LA remodeling occurring in patients with AF.10 
However, cardiac findings in particularly young ESUS 
and cryptogenic stroke patients (aged <50 years) have 
been described very scarcely in the literature—one of 
the findings being thicker epicardial fat.11
We sought to evaluate whether advanced echocar-
diography methods can detect differences in LA me-
chanical function between young cryptogenic stroke 
patients and stroke- free controls and hence signs of 
atrial cardiopathy even at a young age.
METHODS
Study Population
The data that support the findings of this study are 
available from the corresponding author upon rea-
sonable request. All participants in this study were 
recruited among those enrolled into the SECRETO 
(Searching for Explanations for Cryptogenic Stroke 
in the Young: Revealing the Etiology, Triggers, and 
Outcome) Trial (NCT01934725), which is an interna-
tional, prospective, multicenter, case- control study of 
young adults (aged 18–49 years) presenting with an 
imaging- positive first- ever ischemic stroke of unde-
termined etiology. The study protocol has been pub-
lished in more detail.12 Patients were included after 
standardized diagnostic procedures, including brain 
magnetic resonance imaging, imaging of intra- and 
extracranial arteries with either computed tomogra-
phy angiography or magnetic resonance angiography, 
and cardiac imaging to rule out established causes 
of ischemic stroke. Hence, no patients with causally 
relevant aortic or carotid pathology were included. 
Cardiac imaging included standardized transthoracic 
and - esophageal echocardiography.13 We screened 
for AF with ≥24- hour Holter monitoring. Patients were 
classified according to ESUS criteria3 as ESUS (+) and 
ESUS (–).
Patients were age and sex matched to stroke- free 
controls in a 1:1 fashion. A list of 20 potential con-
trols per 1 patient were randomly identified from the 
Population Registry, with an invitation letter sent to 
controls 1 by 1. If this strategy did not result in a fit, 
willing control person, patients’ nonrelated proxies or 
proxies of the study personnel were recruited. Detailed 
clinical history was recorded from all study subjects, in-
cluding arterial blood pressure, height, weight, alcohol 
consumption, and presence of right- to- left shunt. The 
definition of right- to- left shunt was a positive finding on 
either transesophageal echocardiography or transcra-
nial Doppler bubble test, and each patient and control 
CLINICAL PERSPECTIVE
What Is New?
• Left atrial dynamics differ between young cryp-
togenic ischemic stroke patients and healthy 
controls.
• This finding supports the hypothesis that under-
lying pathophysiology is cardioembolism in part 
of the early-onset cryptogenic strokes.
What Are the Clinical Implications?
• Although the results give a clue regarding dis-
ease mechanism, more research is needed 
to explore whether altered left atrial dynam-
ics should alter current secondary prevention 
options.
Nonstandard Abbreviations and Acronyms
ACE angiotensin converting enzyme 
AF atrial fibrillation 
ATR angiotensin receptor 
BMI body-mass index 
ESUS  embolic stroke of undetermined 
source 
LA left atrium 
LAA left atrial appendage 
LAMDV left atrial mid-diastolic volume 
LALDV  left atrial late diastolic volume
LASV  left atrial stroke volume
LAVmax  left atrial volume, maximum
LAVmin  left atrial volume, minimum
LV  left ventricular
SR  strain rate
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underwent at least one of these tests. Participants 
were dichotomized according to their right- to- left 
shunt status. Patients with previous patent foramen 
ovale closure were excluded from this substudy.
The inclusion period for this substudy was from 
December 2013 to May 2017. Written informed consent 
was obtained from all study subjects. The SECRETO 
has been approved by the ethics committee of Helsinki 
and Uusimaa Hospital District.
Echocardiography Methods
The same echocardiographist (J.Pi.) examined all 
patients and control subjects blinded to the case- 
control status with a General Electric Vivid E9 ver-
sion 113 cardiac ultrasound device, using M5Sc and 
4V probes (General Electric, Horten, Norway). Basic 
left ventricular (LV) measurements were obtained 
from the parasternal long- axis view. Measurements 
of mitral inflow E wave and A wave were obtained 
from the apical 4- chamber view using the pulsed 
wave Doppler, and e’ velocity was measured using 
tissue Doppler imaging. Tricuspid regurgitation ve-
locity was assessed from a projection optimized to 
the regurgitation jet. Diastolic function of patients and 
controls was evaluated using the American Society 
of Echocardiography and European Association of 
Cardiovascular Imaging guidelines, with a modifica-
tion of LA volume (LAV) index, which was measured 
with 4- dimensional (4D) volumetry and not using the 
Simpson method, given that it is more sensitive using 
the same cut- off value of 34 mL/m2.14
From the apical view, both LV and LA 2- dimensional 
measurements and 4D measurements were ob-
tained. A true apical view was verified using the tri-
plane mode. The apical 4- chamber view was defined 
as long- axis trans- secting the LV apex and the mitral 
orifice and maximizing the LV and right ventricular 
area. The 2- chamber view was defined as a coun-
terclockwise virtual rotation of 60 degrees, hence 
viewing the LV and LA. The 3- chamber view was 
defined as a further counterclockwise virtual rota-
tion of 60 degrees, hence viewing the LV, ascending 
aorta, and LA. In addition to these 3 planes, a fine- 
tuned virtual rotation was used to obtain an apical 
view where the LAA orifice was as large as possible, 
used only for the LAA orifice minimum and maximum 
measurements. LAA orifice variation was defined as 
(LAA orifice maximum)−(LAA orifice minimum) and 
LAA orifice relative variation as (maximum- minimum)/
maximum (Figure 1).
LV 4D measurements were obtained from an 
apical view using multibeat acquisition of 6 cardiac 
cycles, zoomed in for only the LV, obtaining ≈50 vol-
umes per second. The LV stroke volume was used 
for calculation of the LA conduit volume.15 LAV was 
determined using the 4D method, zoomed in for only 
the LA, and using a 4- cycle multibeat method with 
a volume rate of ≈50 volumes per second. LAV was 
analyzed in 4 stages of the cardiac cycle, from the 
volume- time curve: maximum volume (LAVmax) at 
the end of ventricular systole, mid- diastolic volume 
after the passive emptying phase, late diastolic vol-
ume just before atrial contraction, and minimum 
volume (LAVmin) after atrial contraction, at the end 
of ventricular diastole. LA reservoir volume was de-
fined as the volume difference between LAVmax 
and LA mid- diastolic volume.15 LA stroke volume 
was defined as (LA late diastolic volume−LAVmin), 
and LA ejection fraction was defined as (LA stroke 
volume/LA late diastolic volume). LA cyclic volume 
change was defined as LAVmax−LAVmin (Figure 2). 
LA passive emptying percentage was defined as 
Figure 1. Rotation angle optimized for left atrial appendage 
orifice measurement. 
In this case, the optimal angle was at −55 degrees (compare: 
4- chamber view is 0 degrees and 2- chamber view is −60 
degrees). Measurement at end of ventricular diastole was 9 mm 
and at end of ventricular systole 21 mm. Hence, the variation was 
12 mm and the relative variation 57%.
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100*(LAVmax–LA late diastolic volume)/(LAVmax−
LAVmin).16 LA conduit volume, as a measurement of 
blood flow passing through the LA without affecting 
its volume, was defined as LV stroke volume−LA 
reservoir volume–LA stroke volume, which was ade-
quate, given that none of the patients had significant 
mitral regurgitation or continuous left- to- right or right- 
to- left shunts.15 LA sphericity index was analyzed 
using the LV sphericity index function of EchoPAC 
version 113 (GE Healthcare 2013).
We also studied LA longitudinal strain using the 
P wave for ECG gating, a method known as epsi-
lon (Figure  3).17 We measured LA strain rate using 
tissue Doppler imaging in accordance with Safir- 
Mardanloo’s method for each wall in all 3 apical 
projections, although only at mid- level (Figure  4).18 
We performed body surface area indexing for LAVs 
and LAA orifice measurements using the Mosteller 
formula.19
Statistical Analysis
We used the Wilcoxon signed- rank test for examining 
differences between groups. Maximum tertile was 
defined as the highest tertile of measurements for 
both patient and control groups and minimum tertiles 
as the lowest tertile of measurements for both patient 
and control groups. Tertiles were analyzed compar-
ing the most pathological tertile of the patient group 
and control group, for each parameter. For dichoto-
mous baseline parameters, we used the McNemar 
test. We did a sensitivity analysis based on right- to- 
left shunt status using the Mann–Whitney U test. All 
analyses used IBM SPSS (version 22; IBM Corp., 
Armonk, NY) or RStudio software (version 1.2.1335; 
RStudio, Boston, MA).
RESULTS
We included a total of 30 patients, of which 22 
(73.3%) fulfilled criteria for ESUS. Of the 30 controls, 
23 were identified from the Population Registry. 
Compared with controls, patients had a higher body 
weight and body mass index and a larger body 
surface area. We found no significant differences 
between patients and controls regarding other es-
tablished cardiovascular risk factors. Patients had 
a higher prevalence of right- to- left shunt (Table  1). 
None of our patients or controls had chronic kid-
ney disease. Patients had significantly higher usage 
of antiplatelets, statins, and angiotensin- converting 
enzyme inhibitors/angiotensin- converting enzyme 
blockers than controls (Table 1).
Figure 2. 4D analysis of left atrial volume cycle and definitions of the 4 volumetric measurement points: left atrial minimum 
volume (LAVmin), left atrial maximum volume (LAVmax), left atrial mid- diastolic volume (LAMDV), and left atrial late diastolic 
volume (LALDV). 
In this patient, LAVmin was 20 mL and LAVmax 50 mL; hence, left atrial cyclic volume change was 30 mL. LAMDV was 28 mL, 
and hence LA reservoir volume was 22 mL. LALDV was 31 mL, and hence LA stroke volume was 11 mL and LA ejection fraction 
11/31 mL=35%. Given that this patient had a left ventricular stroke volume (LVSV) of 87 mL, the left atrial conduit volume was 54 mL 
(LVSV – LA reservoir volume – LA stroke volume). 4D indicates 4- dimensional; and LA, left atrium.
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Performance of Measurements
LV basic measurements could be obtained in all study 
subjects, as were the diastolic measures of mitral in-
flow E and A. Also, septal and lateral e’, as well as LAV 
index, could be obtained in all subjects. Tricuspid re-
gurgitation velocity measurement was successful in 
23 patients and 23 controls (both 76.7%). LAA orifice 
diameter measurements were successful in 29 case- 
control pairs, LA volumetry in 30 pairs, LA speckle 
tracking epsilon analyses in 26 pairs, and tissue 
Doppler strain rate in 28 pairs.
Analysis of LV Systolic and Diastolic 
Function
LV basic measurements did not differ significantly be-
tween the 2 groups (Table  2). No study subjects had 
an average E/e’ >14. Three patients and 6 controls had 
impaired e’ velocity of either the septal or lateral mitral 
annulus. One control subject and no patients had tricus-
pid regurgitation velocity of >2.8 m/s. Five patients and 
6 controls had enlarged LAV index, using the 34- mL/
m2 cut- off value. None of the participants fulfilled more 
than one of the aforementioned criteria for evaluating 
diastolic function, and hence all patients and controls 
had a normal diastolic function according to American 
Society of Echocardiography/European Association of 
Cardiovascular Imaging criteria.
Analysis of LA Dynamics
LA reservoir volume was significantly lower in the 
stroke patient group, as was the positive epsilon 
(Table  2). In analysis by tertiles, stroke patients dif-
fered from controls regarding LAA orifice variation 
(lowest tertile), LA cyclic volume change (lowest ter-
tile), and LA strain rate (highest, ie, least negative, 
tertile; Table 3). In sensitivity analysis, LA cyclic vol-
ume change and LA reservoir volume were smaller 
in participants with right- to- left shunt than in those 
without (Table  4). Also, when analyzing the patient 
and control groups separately, we found no signifi-
cant differences between patients with or without 
right- to- left shunt (Tables S1 and S2).
DISCUSSION
To the best of our knowledge, this is the first study to 
investigate LA functional parameters in young crypto-
genic stroke patients with advanced echocardiography. 
We selected stroke- free young adults for our control 
group, in order to detect atrial risk factors for cryptogenic 
Figure 3. LA epsilon analysis. Note the ECG gating set at the P wave. 
Following the dotted white line, expressing the epsilon of the entire left atrium, a negative maximum of 12.5 can be noted in the 
4- chamber view and a negative maximum of 12.6 in the 2- chamber view. The positive maximums are 33.8 and 20.6, respectively. 
Hence, the global negative epsilon peak was 12.6 and the global positive epsilon peak 27.2, calculated as means of the 2 views. LA 
indicates left atrium.D
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Figure 4. LA strain rate (SR) using tissue Doppler imaging of the 6 mid- level points of 
the LA, in all 3 the apical projections (upper 4- chamber, middle 2- chamber, and lower 
3- chamber). 
The 3 SR measurements of the septum are −1.9, −2.6, and −2.2, hence the mean is −1.7. The 
means of the lateral, inferior, anterior, posterior, and anteroseptal walls are −4.5, −1.7, −1.4, −2.4, 
and −2.6, respectively. Hence, the global mean is −2.38 for this patient. LA indicates left atrium.
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stroke in the general population, and to study whether 
atrial findings may play a role in cryptogenic stroke. 
We found the most obvious differences between pa-
tients and controls in early diastolic volume and strain 
changes, represented by LA reservoir volume and posi-
tive peak epsilon value. In analysis by tertiles, we further 
found that patients differed from controls with respect to 
LAA orifice variation, LA cyclic volume change, and LA 
strain rate. Part of the explanation of the difference in LA 
reservoir volume and LA cyclic volume change might 
be attributable to right- to- left shunt, given that these 
parameters reached statistical significance stratified by 
patent foramen ovale (±). However, this shunt is not con-
tinuous, and hence it seems probable that the volume 
differences are attributable to other reasons.
A recent study including older ESUS patients 
found that ESUS patients had lower LA emptying 
fraction and higher LA end- diastolic (ie, minimum) 
volume, compared with healthy individuals.20 As in 
that study, our participants exhibited “supernormal” 
Table 1. Baseline Clinical Data of Patients and Controls
Patients Controls P Value
Body measurements
Height 172 (14) 168 (16) 0.069
Weight 86.8 (30) 75.5 (27) 0.012
Waist circumference, 
cm
98.8 (19.8) 88.5 (19.9) 0.015
Body mass index 30.2 (7.2) 26.1 (6.7) 0.026
Body surface area 2.04 (0.44) 1.88 (0.41) 0.007
Systolic blood 
pressure
128 (21) 129 (21) 0.256
Diastolic blood 
pressure
86 (14) 82 (15) 0.303
Age at 
echocardiography, y
43 (12) 44 (13) 0.098
Cardiovascular risk factors
Male sex 15 (50) 15 (50) 1.000
Hypertension 9 (30) 3 (10) 0.146
Diabetes mellitus, 
type 1
1 (3.3) 0 N/A
Current smoking 9 (30) 11 (36.7) 0.774
Excessive alcohol use 9 (30) 3 (10) 0.031
Physical inactivity 3 (10) 2 (6.7) 1.000
Right- to- left shunt 22 (73.3) 10 (33.3) 0.002
Cardiovascular medication usage
Antiplatelets 28 (93.3) 0 <0.001
Statins 21 (70) 0 <0.001
Beta- blockers 3 (10) 0 0.250
ACE inhibitors/ATR 
blockers
15 (50) 0 <0.001
Spironolactone 1 (3.3) 0 1.000
Other diuretics 2 (6.7) 0 0.500
Anticoagulant 2 (6.7) 0 0.500
Body measurements: numbers are median (interquartile range); 
cardiovascular risk factors: numbers are n (%). For medication, numbers 
are n (%). ACE indicates angiotensin- converting enzyme; ATR, angiotensin 
receptor; and N/A, not applicable.
Table 2. Comparison of Echocardiographic Findings 
Between Stroke Patients and Controls
Patients Controls
P 
Value
LV basic measurements
LV maximum internal 
diameter (diastolic), mm
49 (7) 50 (8) 0.413
Interventricular septum 
diameter (diastolic), mm
10 (2) 10 (2) 0.609
LV posterior wall diameter 
(diastolic), mm
8 (8–10) 9 (7–10) 0.776
LV maximum internal 
diameter (systolic), mm
33 (7) 31 (7) 0.306
LV end- diastolic volume (4D), 
mL/m2
55.03 
(17.40)
56.54 
(20.40)
0.131
LV end- systolic volume (4D), 
mL/m2
20.97 
(8.61)
23.67 
(11.65)
0.125
LV stroke volume, mL/m2 (4D) 32.84 
(13.19)
36.65 
(12.84)
0.329
LV ejection fraction (4D) 62 (14) 59 (15) 0.462
LAA orifice analysis
LAA orifice minimum,  
mm/m2
2.6 (1.6) 3.0 (1.9) 0.256
LAA orifice maximum,  
mm/m2
7.7 (4.0) 9.2 (3.0) 0.294
LAA orifice variation, mm/m2 5.49 (3.31) 6.64 (2.89) 0.265
LAA orifice relative variation, % 69 (19) 67 (16) 0.964
LA volumetry
LA minimum volume, mL/m2 10.6 (6.6) 10.5 (4.3) 0.558
LA maximum volume,  
mL/m2
25.9 (9.9) 27.5 (9.9) 0.136
LA mid- diastolic volume, 
mL/m2
14.6 (6.3) 15.1 (7.2) 0.644
LA late- diastolic volume, 
mL/m2
16.5 (7.0) 17.8 (7.9) 0.417
LA reservoir volume, mL/m2 10.2 (5.4) 13.2 (5.4) 0.030
LA stroke volume, mL/m2 4.78 (5.01) 6.32 (5.99) 0.517
LA ejection fraction 37.5 (26) 39.5 (18) 0.888
LA cyclic volume change, 
mL/m2
14.5 (8.8) 17.7 (5.8) 0.116
LA conduit volume, mL/m2 16.72 
(13.66)
18.57 
(16.74)
0.959
LA passive emptying % 55.9 (28.3) 63.2 (18.3) 0.428
LA sphericity index 0.355 
(0.24)
0.29 (0.22) 0.198
LA strain/epsilon analysis
Negative epsilon peak 12.58 
(5.19)
14.13 
(2.22)
0.322
Positive epsilon peak 17.8 (8.5) 20.8 (10.1) 0.023
LA epsilon peak values 
negative/positive
0.68 (0.43) 0.64 (0.23) 0.367
LA strain rate −2.4 (0.8) −2.8 (0.8) 0.014
Numbers are median (interquartile range). 4D indicates 4- dimensional; LA, 
left atrium; LAA, left atrial appendage; and LV, left ventricular.
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LA maximum volumes (patients, 25.7  mL/m2 versus 
controls, 28.6 mL/m2), given that the upper limit is re-
garded as slightly over 40/mL/m2 using the 4D volum-
etry method.21,22 The differences in LAV variation can, 
in our case- control study, be detected by differences 
in LA reservoir volume and positive epsilon and sup-
ported by the analysis by tertiles of LA cyclic volume 
change. However, unlike in the previous study,20 we 
did not find differences in LA sphericity index between 
patients and controls, which might be attributable to 
milder LA pathology in our younger population.
An earlier cardiac magnetic resonance imaging 
study including older patients found a trend of lower 
LAV change in stroke patients with undetermined stroke 
compared with patients with determined noncardiac 
causes. Interestingly, in that study, patients with unde-
termined stroke also had more atrial fibrosis detected 
by magnetic resonance imaging, despite no difference 
in LA maximum volume.23 Although all of our tertiles of 
both stroke patients and controls had normal LV ejection 
fraction, and no patients or controls fulfilled the criteria 
for diastolic dysfunction, there still might be differences 
in LV loading conditions attributed to subclinical dia-
stolic dysfunction. However, a finding pointing strongly 
toward the altered LA dynamics being attributable to 
primary LA abnormality is the similarity in LAVmin be-
tween the groups, LAVmin being a sensitive marker of 
diastolic dysfunction.24 In the lack of knowledge on LV 
filling pressure and LA fibrosis, we cannot draw conclu-
sions on whether the differences in LA dynamics are 
Table 3. Most Pathological Tertile Analysis of LA 
Echocardiographic Parameters Between Stroke Patients 
and Controls
Patients Controls
P 
Value
LAA orifice analysis
LAA orifice minimum, mm/
m2 (highest)
3.44 (0.90) 3.89 (0.54) 0.123
LAA orifice maximum, 
mm/m2 (highest)
10.60 
(3.46)
11.15 (0.82) 0.478
LAA orifice variation, mm/
m2 (lowest)
3.88 (0.75) 4.35 (0.90) 0.043
LA volumetry
LA minimum volume, mL/
m2 (highest)
14.50 (2.26) 14.51 (2.50) 0.797
LA maximum volume, mL/
m2 (highest)
30.95 
(4.93)
34.03 
(3.35)
0.270
LA mid- diastolic volume, 
mL/m2 (highest)
19.72 (7.03) 19.97 (3.02) 0.519
LA late- diastolic volume, 
mL/m2 (highest)
21.71 (6.14) 22.91 
(3.49)
0.171
LA reservoir volume, mL/
m2 (lowest)
5.61 (3.01) 9.01 (2.57) 0.023
LA stroke volume, mL/m2 
(highest)
10.16 (4.10) 10.57 (4.81) 0.748
LA ejection fraction 
(lowest)
21.5 (6.5) 26.5 (8.75) 0.362
LA cyclic volume change, 
mL/m2 (lowest)
9.17 (2.84) 12.84 (3.52) 0.019
LA conduit volume, mL/
m2 (highest)
23.75 (7.19) 26.53 
(4.37)
0.945
LA passive emptying % 
(lowest)
37.1 (10.2) 39.7 (18.0) 0.326
LA sphericity index 
(highest)
0.51 (0.14) 0.48 (0.10) 0.165
LA strain analysis
Negative epsilon peak 
(highest)
17.35 (3.75) 15.5 (0.90) 0.554
Positive epsilon peak 
(lowest)
14.23 (0.41) 15.53 
(3.08)
0.151
LA epsilon peak values 
negative/positive (highest)
1.01 (0.10) 0.91 (0.25) 0.148
LA strain rate (highest, ie, 
least negative)
−1.8 (0.55) −2.3 (0.55) 0.021
Whether the highest or lowest tertile is considered the most pathological 
is expressed on each row after the parameter name. Numbers are median 
(interquartile range). LA indicates left atrium; and LAA, left atrial appendage.
Table 4. Comparison of LA Findings in Patients and 
Controls, Based on Right- to- Left Shunt Status
Patients and Controls PFO (+) PFO (−) P Value
LAA orifice minimum, 
mm/m2
3.05 (1.63) 2.89 (1.91) 0.513
LAA orifice maximum, 
mm/m2
8.72 (3.40) 8.83 (3.61) 0.533
LAA orifice variation, 
mm/m2
5.81 (2.59) 6.17 (3.25) 0.369
LAA orifice relative 
variation, %
66.7 (14.7) 71.4 (19.7) 0.286
LA minimum volume, 
mL/m2
9.42 (5.50) 11.08 (5.18) 0.351
LA maximum volume, 
mL/m2
25.19 (8.78) 27.21 (8.48) 0.083
LA mid- diastolic 
volume, mL/m2
13.94 (7.67) 15.15 (6.14) 0.266
LA late- diastolic 
volume, mL/m2
16.73 (8.25) 16.42 (6.11) 0.524
LA reservoir volume, 
mL/m2
10.4 (5.3) 13.2 (6.6) 0.042
LA stroke volume, 
mL/m2
5.74 (5.83) 5.55 (5.01) 0.790
LA ejection fraction 40.5 (17.25) 39.0 (26.0) 0.947
LA cyclic volume 
change, mL/m2
14.7 (7.0) 17.9 (6.1) 0.039
LA conduit volume, 
mL/m2
19.4 (10.9) 16.2 (16.9) 0.382
LA passive emptying % 55.1 (29.9) 63.3 (18.1) 0.100
LA sphericity index 0.29 (0.19) 0.35 (0.27) 0.604
Negative epsilon peak 13.7 (5.3) 13.5 (3.2) 0.915
Positive epsilon peak 19.8 (11.6) 20.4 (6.4) 0.762
LA epsilon peak values 
negative/positive
0.68 (0.37) 0.64 (0.31) 0.922
LA strain rate −2.6 (1.0) −2.5 (0.7) 0.939
Numbers are median (interquartile range). LA indicates left atrium; LAA, 
left atrial appendage; and PFO, patent foramen ovale.
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secondary to LV conditions or attributable to primary 
LA disease. However, because of that study’s finding 
of more LA fibrosis in patients with otherwise similar LA 
dynamics as in our participants, we think it is likely that 
also younger cryptogenic stroke patients have slightly 
abnormal LA dynamics attributable to LA fibrosis (ie, 
representing primary LA disease).23 An explanation for 
why the difference emerged only in the volume change 
of LA is that atrial fibrosis dampens the LA’s ability to 
stretch and contract and hence change its volume, al-
though, in the lack of LV failure, there is no increased LV 
filling pressure to stretch the LA.
Another finding of ours that points toward primary 
atrial disease is the significant difference in the lowest 
tertiles of LA strain rate. In AF, contractility of the LA is 
also dampened, detected by strain rate.25 AF is well 
known to be associated with atrial fibrosis.26 Perhaps 
the lower contractility of atrial tissue in patients with 
paroxysmal AF is also attributable to atrial fibrosis. 
However, AF is unlikely in the age group of our pa-
tients, and hence it seems more probable that they 
only have mild atrial fibrosis. Our novel method of LAA 
orifice analysis from the apical projection has a similar 
profile as LAV and epsilon values: no differences in 
maximum values, but the variation between minimum 
and maximum values was lower in the stroke patient 
group. Interestingly, a larger LAA orifice diameter has 
been suggested as a stroke risk factor in general AF 
patients.27
Strengths of our study include a systematic and 
well- matched case- control participant population, a 
prospective design, a precise protocol with very few 
missing data, blinding of the echocardiographist until 
all measurements were performed, and the use of 
modern echocardiography methods such as 4D vol-
umetry and epsilon. The similar findings of lower LA 
variation, in both epsilon and volumetry in the stroke 
patient group, together with lowered strain rate, are 
findings that complement each other in the conclusion 
of altered LA dynamics. Weaknesses, in turn, include 
the small sample size, possible selection bias and 
other shortcomings inherent to case- control studies, 
and lack of invasive LV filling pressure measurements. 
The small sample size also restricted our possibility to 
adjust for confounders. Thus, we could not firmly de-
termine whether the differences in LA dynamics were 
of a primary nature or secondary to differing LV filling 
conditions.
CONCLUSIONS
Our pilot study showed that LA dynamics differed be-
tween young cryptogenic stroke patients and stroke- 
free controls, when measured with advanced cardiac 
ultrasound techniques. However, there were only slight 
differences in some parameters and no differences in 
the rest. Future studies should include larger patient 
populations to increase discriminatory power, allow for 
relevant subgroup analyses (eg, stratified by  patent fora-
men ovale status), and differentiating between  primary 
atrial disease and secondary differences  reflecting LV 
function.
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Table S1. Comparison of left atrial echocardiographic findings between stroke patients with PFO and 
without PFO. 
 
 
 
 
LAA, Left atrial appendage 
LA, Left atrium 
 
  
LAA orifice analysis PFO (+) PFO (-) P-value 
LAA orifice minimum, mm/m2 3.04 (1.37) 1.87 (2.33) 0.135 
LAA orifice maximum, mm/m2 7.73 (3.69) 7.45 (7.48) 0.862 
LAA orifice variation, mm/m2 5.58 (2.68) 4.95 (8.27) 1.000 
LAA orifice relative variation, % 67 (16) 79 (30) 0.199 
LA volumetry    
LA minimum volume, ml/m2 8.98 (7.67)  11.61 (5.20) 0.344 
LA maximum volume, ml/m2 23.66 (8.10) 25.94 (10.77) 0.256 
LA mid diastolic volume, ml/m2 14.25 (6.09) 14.98 (3.99) 0.420 
LA late diastolic volume, ml/m2 16.36 (6.89) 16.01 (5.04) 0.597 
LA reservoir volume, ml/m2 9.49 (6.89) 11.40 (10.78) 0.185 
LA stroke volume, ml/m2 5.58 (5.92) 4.12 (3.79) 0.836 
LA ejection fraction 42 (21) 24.5 (30) 0.696 
LA cyclic volume change, ml/m2 15.28 (8.06) 14.51 (9.15) 0.277 
LA conduit volume, ml/m2 19.54 (11.18) 14.57 (14.03) 0.156 
LA passive emptying % 55.0 (33.7) 69.8 (19.1) 0.097 
LA sphericity index* 0.33 (0.20) 0.35 (0.51) 0.909 
LA strain/epsilon analysis    
Negative epsilon peak 13.55 (5.70) 12.58 (6.73) 0.651 
Positive epsilon peak 17.45 (8.00) 20.78 (8.71) 0.735 
LA epsilon peak values negative/positive 0.70 (0.44) 0.59 (0.46) 0.651 
LA strain rate -2.50 (1.50) -2.35 (0.50) 0.909 
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Table S2. Comparison of left atrial echocardiographic findings between controls with PFO and without 
PFO. 
 
LAA, Left atrial appendage 
LA, Left atrium 
LAA orifice analysis PFO (+) PFO (-) P-value 
LAA orifice minimum, mm/m2 3.08 (2.02) 2.95 (1.88) 0.779 
LAA orifice maximum, mm/m2 10.51 (3.57) 9.10 (3.14) 0.983 
LAA orifice variation, mm/m2 6.85 (2.53) 6.52 (2.49) 0.846 
LAA orifice relative variation, % 65 (11) 68 (17) 0.619 
LA volumetry    
LA minimum volume, ml/m2 11.41 (3.69) 10.48 (5.90) 0.880 
LA maximum volume, ml/m2 27.19 (9.25) 28.65 (8.45) 0.619 
LA mid diastolic volume, ml/m2 12.72 (8.95) 15.15 (6.38) 0.559 
LA late diastolic volume, ml/m2 18.57 (9.38) 16.99 (8.11) 1.000 
LA reservoir volume, ml/m2 11.06 (4.29) 13.60 (5.90) 0.530 
LA stroke volume, ml/m2 6.67 (6.42) 5.77 (6.53) 0.914 
LA ejection fraction 32.0 (16.5) 39.5 (21.8) 0.779 
LA cyclic volume change, ml/m2 14.41 (5.19) 17.99 (4.95) 0.214 
LA conduit volume, ml/m2 19.36 (11.55) 16.43 (17.53) 0.846 
LA passive emptying % 61.9 (24.2) 63.3 (20.9) 0.713 
LA sphericity index 0.29 (0.08) 0.33 (0.25) 0.155 
LA strain/epsilon analysis    
Negative epsilon peak 15.00 (4.03) 13.75 (3.15) 0.350 
Positive epsilon peak 26.00 (10.17) 20.40 (7.81) 0.530 
LA epsilon peak values negative/positive 0.57 (0.25) 0.70 (0.28) 0.880 
LA strain rate -3.00 (0.95) -2.75 (0.78) 0.390 D
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